The 6 analysts offering 12-month price forecasts for Allena Pharmaceuticals Inc have a median target of 6.50, with a high estimate of 26.00 and a low estimate of 1.00. The median estimate represents a +339.19% increase from the last price of 1.48.
The current consensus among 7 polled investment analysts is to Buy stock in Allena Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.24
Reporting Date Dec 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.